Showing 2,387 news articles about HIV treatment

Filters Content type: Editors' picks Topic: HIV treatment

Treatment is recommended for all people living with HIV. It involves taking a combination of antiretroviral drugs. This stops the virus from replicating and allows the immune system to strengthen and fight infections.

Retention & linkage to care

African-Americans most likely to stop taking meds in Medicare Part D's coverage gap

Editor's pick
Eurekalert Medicine & Health
17 August 2015
Ageing & HIV

Top five concerns people with HIV have about ageing: Scotland

Editor's pick
HIV Scotland-
12 August 2015
Resistance

Pretreatment HIV drug resistance leads patients to switch to second-line ART

Editor's pick
Healio
11 August 2015
Treatment outcomes & life expectancy

Life expectancy of HIV-positive Canadians rises to 65 years: study

Editor's pick
CTV News
10 August 2015
Activism & civil society

Four years with HIV and counting…

Editor's pick
Beyond Positive
4 August 2015
Access to healthcare

Medicines Patent Pool At 5 Years: Promises Kept, Changes Ahead – An Interview With Greg Perry

Editor's pick
Intellectual Property Watch
4 August 2015
Pharmaceutical industry

GSK flags up pipeline as HIV drugs help it beat profit forecasts

Editor's pick
Reuters
30 July 2015
Starting treatment

Stribild Superior to Boosted Atazanavir in Treatment-Naive Women

Editor's pick
NATAP
27 July 2015
Starting treatment

The Day the HIV Treatment Pendulum Stopped Swinging

Editor's pick
The Body Pro
23 July 2015
Adherence

Africa: MSF Warns Successful Global HIV Response Will Require Bigger Emphasis On Adherence

Editor's pick
AllAfrica
22 July 2015
Access to healthcare

IAS 2015: While “game-changing,” START trial draws “line in the sand” and sets “time a’ ticking” to stop preventable illnesses and death, calls for action are accompanied by questions of impact of inequities, obstacles

Editor's pick
Science Speaks
21 July 2015
HIV treatment

European Commission Approves Bristol-Myers Squibb’s Evotaz (atazanavir and cobicistat fixed-dose combination) for the Treatment of HIV-1 Infection in Adults

Editor's pick
BMS press release
20 July 2015
Pharmaceutical industry

TAG Pipeline Report

Editor's pick
TAG
17 July 2015
New & experimental HIV treatments

Evidence of HIV Suppression With PRO 140 Monotherapy Reaching Nearly 11 Months

Editor's pick
CytoDyn press release
16 July 2015
Access to healthcare

People with HIV live almost 20 years longer than in 2001

Editor's pick
The Guardian
14 July 2015
Access to healthcare

UNAIDS announces that the goal of 15 million people on life-saving HIV treatment by 2015 has been met nine months ahead of schedule

Editor's pick
UNAIDS
14 July 2015
New & experimental HIV treatments

Scripps Research Institute-Designed Drug Candidate Significantly Reduces HIV Reactivation Rate

Editor's pick
Scripps Research Institute
11 July 2015
PrEP

Could a Subdermal Implant Mean the End of HIV?

Editor's pick
Edge San Francisco
6 July 2015
Improving HIV care

Meet the Khayelitsha compliers club

Editor's pick
Mail & Guardian
6 July 2015
Adherence

Adherence All-Stars

Editor's pick
CATIE
6 July 2015
Condoms & lubricant

No, Teens Did Not Create a Working Condom That Changes Colors if You Have an STI, and Maybe They Shouldn’t

Editor's pick
RH Reality Check
6 July 2015
Treatment guidelines

NHS England announces annual investment decisions for certain specialised services [including HIV treatment as prevention]

Editor's pick
NHS England press release
3 July 2015
New & experimental HIV treatments

Gilead Submits New Drug Application to U.S. Food and Drug Administration for Single Tablet Regimen for HIV Containing Rilpivirine, Emtricitabine and Tenofovir Alafenamide

Editor's pick
Gilead press release
2 July 2015
HIV treatment

South Korea mulls combining HIV drugs with antivirals to combat MERS

Editor's pick
in-Pharma Technologist
22 June 2015